Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2024
12/31/2023
Revenue
62
54
27
Revenue Growth (YoY)
--
100%
--
Cost of Revenue
16
7
3
Gross Profit
46
20
9
Selling, General & Admin
65
29
21
Research & Development
26
14
7
Operating Expenses
91
95
60
Other Non Operating Income (Expenses)
0
0
0
Pretax Income
-45
-48
-37
Income Tax Expense
--
--
--
Net Income
-46
-49
-37
Net Income Growth
--
32%
--
Shares Outstanding (Diluted)
21.08
26.51
26.51
Shares Change (YoY)
--
0%
--
EPS (Diluted)
-2.2
-1.87
-1.42
EPS Growth
--
31%
--
Free Cash Flow
-42
-51
-35
Free Cash Flow Per Share
--
--
--
Gross Margin
74.19%
37.03%
33.33%
Operating Margin
-72.58%
-88.88%
-137.03%
Profit Margin
-74.19%
-90.74%
-137.03%
Free Cash Flow Margin
-67.74%
-94.44%
-129.62%
EBITDA
-45
-48
-37
EBITDA Margin
-72.58%
-88.88%
-137.03%
D&A For EBITDA
0
0
0
EBIT
-45
-48
-37
EBIT Margin
-72.58%
-88.88%
-137.03%
Effective Tax Rate
--
--
--
Follow-Up Questions
What are IM Biometrics Inc's key financial statements?
According to the latest financial statement (Form-10K), Carlsmed Inc has a total asset of $51, Net loss of $-49
What are the key financial ratios for HLCN?
Carlsmed Inc's Current ratio is 1.96, has a Net margin is -90.74, sales per share of $2.03.
How is IM Biometrics Inc's revenue broken down by segment or geography?
Carlsmed Inc largest revenue segment is Aprevo, at a revenue of 27,165,000 in the most earnings release.For geography, United States is the primary market for Carlsmed Inc, at a revenue of 27,165,000.
Is IM Biometrics Inc profitable?
no, according to the latest financial statements, Carlsmed Inc has a net loss of $-49
Does IM Biometrics Inc have any liabilities?
yes, Carlsmed Inc has liability of 26
How many outstanding shares for IM Biometrics Inc?
Carlsmed Inc has a total outstanding shares of 26.51